Search

Insights

Featured

Implanted telemetry in preclinical research

Implanted telemetry is established as the gold standard for preclinical Drug Development, Safety Pharmacology and Toxicology studies. Let’s understand how it evolved in the last decade and what are the current challenges faced by scientists.

Read more »

All posts

Rats for cardiovascular research

Because of the multifactorial nature of cardiovascular diseases, there is not a single specie which is optimal for all studies. The choice of an animal model should be carefully made as it can affect the experimental outcomes and the reasonable translation of study findings to humans.

Read more »
myocardial infarction
Cell-based & cell-free therapies for myocardial infarction

After myocardial infarction, the heart fails to regenerate and ischemic/reperfusion injury leads to cardiomyocyte loss and fibrosis leading to impaired heart function. The medical treatment for heart failure, for the most part, is not disease modifying, it’s simply symptomatic. Another strategy is to address the fundamental issue of a failing heart, which is the loss of cardiomyocytes after a heart attack.

Read more »
Implanted telemetry in preclinical research

Implanted telemetry is established as the gold standard for preclinical Drug Development, Safety Pharmacology and Toxicology studies. Let’s understand how it evolved in the last decade and what are the current challenges faced by scientists.

Read more »
Lung Science Conference 2022

The Estoril 20th ERS Lung Science Conference (LSC) brought forward the importance of mucosal immunology through amazing presentations and posters and emka TECHNOLOGIES was happy to participate in this event.

Read more »
Muscular Dystrophy

Among muscular dystrophies, Duchenne Muscular Dystrophy is the most common and most severe form. Learn more about the current status of the research.

Read more »
Gastrointestinal motility

The evaluation of the gastrointestinal (GI) motility is useful to detect pathological conditions of the GI system, the therapeutic potential of drugs in motility disorders or potential drug side effects on motility or inflammation.

Read more »
SEND-export
Integrating SEND outcomes

As an industry partner with deep expertise in IND-enabling studies, emka TECHNOLOGIES helps nonclinical scientists comply with SEND requirements by generating SEND 3.1 compatible tables directly from emka TECHNOLOGIES software.

Read more »

Empowering researchers

Welcome to emka TECHNOLOGIES knowledge center.
You can find everything from FAQ to document ressources to a complete list of emka publications in this section. 
Everything you need to get the most out of your emka solutions.

By browsing this website, you accept the use of cookies for statistical purposes.

Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are set through our site by our advertising partners.

Google Adwords
We use Adwords to track our Conversions through Google Clicks.

Hubspot
We use Hubspot to monitor our traffic and to help us AB test new features.

Google Tag Manager

Save